Filter
378
Filtered Results: 378
Text search:
Lopinavir/Ritonavir
Featured
Recommendations
54
New Publications
92
Language
Document type
No document type
212
Guidelines
97
Studies & Reports
29
Fact sheets
15
Manuals
13
Resource Platforms
4
Training Material
3
Strategic & Response Plan
3
Infographics
2
Countries / Regions
India
16
Brazil
12
Tanzania
11
Latin America and the Carribbean
10
Paraguay
10
South Africa
10
Nepal
8
Mozambique
8
Kenya
7
Germany
6
Russia
6
Namibia
6
Rwanda
5
Nigeria
5
Senegal
5
Malawi
5
Congo, Democratic Republic of
5
Ethiopia
5
Bangladesh
4
Uganda
4
Colombia
3
Ukraine
3
Burkina Faso
3
Global
3
Haiti
3
Cambodia
3
Bolivia
3
Argentina
3
Angola
3
Zambia
3
Myanmar / Burma
3
Madagascar
3
Thailand
2
Lesotho
2
Ghana
2
Benin
2
China
2
Chile
2
Cameroon
2
Peru
2
Zimbabwe
2
Africa
2
Venezuela
2
West and Central Africa
2
Middle East and North Africa
2
France
2
Spain
2
East and Southern Africa
2
Botswana
2
Ecuador
2
North Macedonia
1
Tajikistan
1
Switzerland
1
El Salvador
1
Turkey
1
Sierra Leone
1
Togo
1
Iran
1
Albania
1
Canada
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Austria
1
Philippines
1
Asia
1
Guinea-Bissau
1
Western and Central Europe
1
Luxembourg
1
Belgium
1
Côte d’Ivoire / Ivory Coast
1
Eastern Europe
1
Djibouti
1
Central African Republic
1
Mali
1
Bhutan
1
South Sudan
1
Indonesia
1
Liberia
1
Solomon Islands
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
198
Clinical Guidelines
36
Women & Child Health
11
Public Health
5
Key Resources
4
Pharmacy & Technologies
4
Capacity Building
3
Toolboxes
HIV
95
COVID-19
80
Pharmacy
29
TB
21
Mental Health
3
Ebola & Marburg
3
Caregiver
2
NTDs
2
Conflict
2
Global Health Education
1
AMR
1
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0190785 January 10, 2018
Цель этого документа – повысить уровень осознания актуальности приоритетных направлений научных исследований по проблеме ТБ/ВИЧ (то есть по тем направлениям, кот...
National Tuberclosis and
Leprosy Programme (NTLP)
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...
Joint WHO/ILO guidelines on post-exposure prophylaxis (PEP) to prevent HIV infection.
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.
The previous edition of the drugs chart is also available to download in Russian.
Indicators for monitoring the 2016 United Nations Political Declaration on Ending AIDS
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country....
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country....
UNAIDS 2018, Guidance
Indicators for monitoring the
2016 Political Declaration on Ending AIDS
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
